Utah Governor’s Office of Economic Development

ContraDyn is a startup focused on commercializing targeted nanoglobular drug delivery systems, which the Center has developed. These novel three dimensional globular structures can carry multiple compounds including small molecule drugs, imaging agents and targeting peptides directly to cancer tumor sites at lower doses, reduced systemic toxicity, and much greater therapeutic efficacy than other delivery technologies. Delivery of offpatent or wellstudied
but unapproved drugs should substantially abbreviate FDA approval requirements.

Dennis Farrar, CEO
417 Wakara Way, Suite 3111
Salt Lake City, UT 84108
(801) 585-6312
denny@upstartvc.com